The current valuation score of Phio Pharmaceuticals Corp is 7.99, ranking 174 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.76, which is -105.96% below the recent high of 0.05 and -18.18% above the recent low of -0.89.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.